Bioforce Nanosciences Holdings BFNH Income Statement (2019-2026)

OTC BFNH
$7.61 -0.90 (-10.58%)
At close: Sep 30, 2026 · 4:00 PM EDT
Reported Financials

Bioforce Nanosciences Holdings Quarterly Income Statement

Periods 27 quarters
Latest Jun 2026

Bioforce Nanosciences Holdings reported net income of -$0.26M for the quarter ended Jun 2026. This income statement covers 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Selling, General & AdministrativeSG&A
0.01M0.01M0.03M0.01M0.02M0.01M0.02M0.01M0.01M0.01M0.03M0.01M0.02M0.02M0.03M0.02M0.01M0.01M0.12M
Other Operating ExpensesOther Opex
0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.14M
Operating ExpensesOpex
0.11M0.12M0.13M0.12M0.12M0.11M0.13M0.11M0.11M0.11M0.13M0.11M0.12M0.12M0.13M0.12M0.12M0.12M0.26M
Operating IncomeOp. Inc
-0.11M-0.12M-0.13M-0.12M-0.12M
EBIT
-0.11M-0.12M-0.13M-0.12M-0.12M-0.12M-0.26M
Non-operating items
Other Non Operating IncomeOther Non Op Inc.
-0.80M
Non Operating IncomeNon Op. Inc.
-0.80M0.02M0.50M
Net income details
EBT
-0.11M-0.12M-0.13M-0.12M-0.12M-0.12M-0.26M
Profit After TaxPAT
-0.11M-0.12M-0.13M-0.12M-0.12M-0.12M-0.26M
Income from Continuing OperationsIncome (Continuing)
-0.11M-0.12M-0.13M-0.12M-0.12M-0.12M-0.26M
Consolidated Net IncomeConsol Net Inc.
-0.11M-0.12M-0.13M-0.12M-0.12M-0.12M-0.26M
Income towards Parent CompanyParent Net Inc
-0.11M-0.12M-0.13M-0.12M-0.12M-0.11M-0.13M-0.11M-0.11M-0.11M-0.13M-0.11M-0.12M-0.12M-0.94M-0.12M-0.12M-0.10M0.24M
Net Income towards Common StockholdersNet Income
-0.11M-0.12M-0.13M-0.12M-0.12M-0.11M-0.13M-0.11M-0.11M-0.11M-0.13M-0.11M-0.12M-0.12M-0.93M-0.12M-0.12M-0.10M0.24M
Additional items
EPS (Basic)
0.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.030.000.000.000.01
EPS (Diluted)
0.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.030.000.000.000.01
Shares Outstanding
29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M32.25M33.52M33.52M33.21M33.52M33.54M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M32.25M33.52M33.52M33.21M33.52M33.54M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M33.52M33.52M33.52M33.52M33.52M33.55M

Bioforce Nanosciences Holdings Income Statement API

Pull Bioforce Nanosciences Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BFNH&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY